This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shen-Ong, G L Articles by Eisenman, R N Search for Related Content PubMed PubMed Citation Articles by Shen-Ong, G L Articles by Eisenman, R N

 Previous Article  |  Next Article 

Mol Cell Biol. 1989 December; 9(12): 5456-5463

A second c-myb protein is translated from an alternatively spliced mRNA expressed from normal and 5'-disrupted myb loci.

Laboratory of Genetics, National Cancer Institute, Bethesda, Maryland 20892.

ABSTRACT

The major protein encoded by the c-myb oncogene in many species has been identified as an unstable, nuclear DNA-binding protein with an apparent molecular mass of 75 to 80 kilodaltons (p75c-myb). Recently, an alternatively spliced form of c-myb-encoded mRNA has been identified in murine cells containing either normal or rearranged c-myb genes. This mRNA includes a new exon, termed E6A, formed through use of cryptic splice sites located in the large intron between c-myb exons vE6 and vE7. E6A is predicted to contribute an internal 121-residue in-frame insertion into a region C terminal of the DNA-binding domain the c-myb-encoded protein. Here we report the identification of an 85-kilodalton (p85c-myb-E6A) protein as the translation product of the alternatively spliced E6A c-myb mRNA. This protein as well as p75c-myb were precipitated with anti-Myb antibodies raised against the conserved DNA-binding region of c-Myb. Proteolytic mapping studies showed that the two proteins are highly related but not identical. However, only the p85 protein reacted with an antiserum prepared against the E6A region expressed in bacteria, demonstrating that p85 but not p75 contains E6A sequences. In addition, the mobilities of both p85 and p75 were increased in myeloid tumor cell lines containing proviral integrations upstream of the 5' coding exons of v-myb, indicating that both proteins are truncated forms of c-Myb expressed from the same disrupted allele. p75c-myb and p85c-myb-E6A were indistinguishable with respect to nuclear localization and protein half-life. Furthermore, both forms of Myb were synthesized continuously throughout the cell cycle in 70Z ore-B cells. The contribution of the E6A domain to c-myb function remains to be elucidated.

This article has been cited by other articles:

• Hanlon, L., Barr, N. I., Blyth, K., Stewart, M., Haviernik, P., Wolff, L., Weston, K., Cameron, E. R., Neil, J. C. (2002). Long-Range Effects of Retroviral Insertion on c-myb: Overexpression May Be Obscured by Silencing during Tumor Growth In Vitro. J. Virol. 77: 1059-1068 [Abstract] [Full Text]  
• Woo, C. H., Sopchak, L., Lipsick, J. S. (1998). Overexpression of an Alternatively Spliced Form of c-Myb Results in Increases in Transactivation and Transforms Avian Myelomonoblasts. J. Virol. 72: 6813-6821 [Abstract] [Full Text]  
• Luscher, B, Eisenman, R N (1990). New light on Myc and Myb. Part II. Myb.. Genes Dev. 4: 2235-2241